| Assay ID | Title | Year | Journal | Article |
|---|
| AID41653 | Agonist activity towards Beta-3 adrenergic receptor | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. |
| AID40131 | Binding affinity towards Beta-1 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. |
| AID41789 | In vitro effective concentration against beta-3 adrenergic receptor. | 2003 | Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
| Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human beta3-adrenergic receptor agonist. |
| AID9298 | Oral bioavailability in dog (p.o. dosing of 0.05 M citric acid/0.05 M hydrochloric acid solution) | 1999 | Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
| L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability. |
| AID41652 | Agonist activity towards Beta-3 adrenergic receptor | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. |
| AID41657 | Agonistic activity against the cloned human Beta-3 adrenergic receptor was measured by its by its ability to stimulate adenylyl cyclase | 1999 | Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
| L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability. |
| AID220785 | Agonistic activity at beta3 adrenergic receptor was measured as adenylyl cyclase activation given as % of the maximal stimulation with isoproterenol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. |
| AID9505 | Oral bioavailability in dog | 2000 | Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
| Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides. |
| AID41645 | Agonistic activity against beta-3 adrenergic receptor as percent adenylyl cyclase activation relative to maximal stimulation with isoproterenol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. |
| AID44560 | Tested in vitro for its ability to stimulate increase in cAMP in CHO cells expressing the cloned human beta-3 adrenergic receptor | 2000 | Bioorganic & medicinal chemistry letters, Sep-18, Volume: 10, Issue:18
| Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides. |
| AID41788 | In vitro agonistic activity against cloned human beta-3 adrenergic receptor using [125I]iodocyanopindolol as radioligand to stimulate increase in cAMP in CHO cells | 1999 | Bioorganic & medicinal chemistry letters, Jul-05, Volume: 9, Issue:13
| Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore. |
| AID41636 | In vitro effective concentration against beta-3 adrenergic receptor. | 2003 | Bioorganic & medicinal chemistry letters, Aug-04, Volume: 13, Issue:15
| Development of 3D-QSAR models in cyclic ureidobenzenesulfonamides: human beta3-adrenergic receptor agonist. |
| AID41171 | Binding affinity towards human Beta-2 adrenergic receptor expressed in CHO cells, using [125I]iodocyanopindolol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. |
| AID40132 | Binding affinity towards human Beta-1 adrenergic receptor expressed in CHO cells, using 125I]iodocyanopindolol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides. |
| AID10090 | Compound was evaluated for the half-life (t 1/2) in hours | 1999 | Bioorganic & medicinal chemistry letters, May-03, Volume: 9, Issue:9
| L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailability. |
| AID41170 | Binding affinity towards Beta-2 adrenergic receptor in CHO cells expressing the cloned human receptor using 125I]iodocyanopindolol | 1999 | Bioorganic & medicinal chemistry letters, Mar-08, Volume: 9, Issue:5
| Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |